SI-BONE, Inc.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
SIBN$25.10-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(17,260) | $(26,418) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 19,547 | 19,734 |
| Depreciation and amortization | 4,132 | 3,166 |
| Accounts receivable credit losses | 537 | 328 |
| Amortization of discount and premium on marketable securities | (2,440) | (4,254) |
| Inventory reserve | 1,784 | 618 |
| Amortization of debt issuance costs | 88 | 127 |
| Loss on disposal of property and equipment | 1,442 | 1,250 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 364 | (3,304) |
| Inventory | (10,334) | (5,922) |
| Prepaid expenses and other assets | 419 | 718 |
| Accounts payable | 1,245 | 1,757 |
| Accrued liabilities and other | (1,927) | (1,403) |
| Net cash used in operating activities | (2,403) | (13,603) |
| Cash flows from investing activities | ||
| Maturities of marketable securities | 156,100 | 186,500 |
| Purchases of marketable securities | (157,840) | (169,983) |
| Purchases of property and equipment | (7,126) | (8,231) |
| Net cash (used in) provided by investing activities | (8,866) | 8,286 |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock under employee stock purchase plan | 1,568 | 1,472 |
| Proceeds from the exercise of stock options | 779 | 564 |
| Net cash provided by financing activities | 2,347 | 2,036 |
| Effect of exchange rate changes on cash and cash equivalents | 461 | 235 |
| Net decrease in cash and cash equivalents | (8,461) | (3,046) |
| Cash and cash equivalents at | ||
| Beginning of period | 34,948 | 33,271 |
| End of period | $26,487 | $30,225 |
| Supplemental disclosure of non-cash information | ||
| Unpaid purchases of property and equipment | $593 | $1,445 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.